Big Money Are Not Betting On Becton Dickinson & Co (NYSE:BDX), Sentiment at 1.05

June 27, 2018 - By Daniel Cummings

Becton, Dickinson and Company (NYSE:BDX) Corporate Logo

Positions for Becton Dickinson & Co (NYSE:BDX)

In 2018 Q1 Becton Dickinson & Co (NYSE:BDX) big money sentiment decreased to 1.05, SEC filings reveal. That’s down -0.50, from 2017Q4’s 1.55. 464 institutional investors increased and started new positions, while 444 sold and decreased equity positions in Becton Dickinson & Co so the sentiment has dropped. Funds own 219.77 million shares, up from 215.77 million shares in 2017Q4. Funds holding Becton Dickinson & Co in top 10 increased from 45 to 48 for an increase of 3. In total 69 funds closed positions, 375 reduced and 350 increased. Also 114 funds bought new Becton Dickinson & Co stakes.

Most Becton Dickinson & Co Investors

As of 2018 Q1 Sirios Capital Management L P has 9.85% invested in Becton Dickinson & Co. Becton Dickinson & Co’s shareholder Caledonia Investments Plc owns 157,800 shares as of 2018 Q1. In addition, Fundsmith Llp reported 3.61 million shares in Becton Dickinson & Co equivalent to 6.44% of its fund portfolio. The Oregon-based fund Jensen Investment Management Inc have invested about 6.24% of the fund’s stock portfolio in Becton Dickinson & Co. The United Kingdom-based fund Waverton Investment Management Ltd looks positive on Becton Dickinson & Co, possessing 450,512 shares.

Becton, Dickinson and Company develops, makes, and sells medical supplies, devices, laboratory equipment, and diagnostic products worldwide.The firm is worth $63.99 billion. It operates in two divisions, BD Medical and BD Life Sciences.Last it reported negative earnings. The BD Medical segment offers syringes, pen needles, and IV sets for diabetes; needles, syringes, and intravenous catheters for medication delivery; prefilled IV flush syringes; regional anesthesia needles and trays; sharps disposal containers; closed-system transfer devices; skin antiseptic products; surgical and laproscopic instrumentations; intravenous medication safety and infusion therapy delivery, and automated medication dispensing and supply management systems; and prefillable drug delivery systems.

BDX touched $239.48 during the last trading session after $4.73 change.Becton, Dickinson and Company is uptrending after having risen 19.79% since June 27, 2017. BDX has 1.72 million volume or 44.37% up from normal. BDX outperformed the S&P 500 by 7.22%.

Earnings report for Becton, Dickinson and Company (NYSE:BDX) is expected on August, 2., RTT reports. Last year’s EPS was $2.46, while now analysts expect change of 15.45 % up from current $2.84 EPS. BDX’s profit could reach $758.86 million with 21.08 P/E in case $2.84 EPS is reported. After $2.65 EPS was reported previous quarter, analysts now see EPS growth of 7.17 % for Becton, Dickinson and Company.

Clarivest Asset Ltd Com reported 733 shs stake. Jane Street Gru Ltd Co owns 7,960 shs. Alliancebernstein Ltd Partnership has 0.07% invested in Becton, Dickinson and Company (NYSE:BDX) for 426,639 shs. 122,038 are owned by Us National Bank De. Denver Inv Limited Company stated it has 0.11% in Becton, Dickinson and Company (NYSE:BDX). Price T Rowe Associate Md owns 35.81M shs for 1.23% of their capital. Pennsylvania-based Hbk Sorce Advisory Lc has invested 0.07% in Becton, Dickinson and Company (NYSE:BDX). Shufro Rose Co Limited Liability Corporation invested in 0.02% or 950 shs. Amica Retiree Tru has 509 shs. Deltec Asset Mngmt Limited Company has invested 0.52% of its capital in Becton, Dickinson and Company (NYSE:BDX). Crawford Counsel Inc has 2,448 shs. Troy Asset Limited accumulated 587,500 shs or 5.19% of the stock. Essex Financial Ser accumulated 4,699 shs. First Midwest National Bank & Trust Tru Division reported 10,056 shs or 0.3% of all its holdings. Glenmede Trust Na owns 24,801 shs.

Becton, Dickinson and Company had 6 selling transactions and 1 insider buy since February 23, 2018. This’s net activity of $9.39 million. The insider Melcher David F bought $112,535. On Friday, May 11 Shabshab Nabil sold $2.31M worth of Becton, Dickinson and Company (NYSE:BDX) or 10,209 shs. On Friday, February 23 RING TIMOTHY M had sold 176 shs worth $38,416. Gallagher John E also sold $1.21M worth of Becton, Dickinson and Company (NYSE:BDX) on Tuesday, February 27. On Monday, February 26 $910,726 worth of stock was sold by Borzi James W. 1,877 shs valued at $426,079 were sold by Polen Thomas E Jr on Tuesday, March 13.

Becton, Dickinson and Company (NYSE:BDX) Ratings Coverage

A total of 12 analysts rate Becton Dickinson (NYSE:BDX) as follows: 9 “Buy”, 3 “Hold” and 0 “Sell”. Тherefore 75% are bullish. The firm has $27500 highest and $235.0 lowest target. The avg target $248.33 is 3.70% above the last ($239.48) price. (NYSE:BDX) has 13 ratings reports on 27 Jun 2018 according to StockzIntelligence. On Friday, January 5 the stock has “Hold” rating by Citigroup. In Friday, December 29 report Deutsche Bank maintained it with “Buy” rating and $260.0 target. On Wednesday, February 7 the firm earned “Equal-Weight” rating by Morgan Stanley. On Thursday, June 21 the rating was upgraded by JP Morgan to “Overweight”. On Thursday, February 8 RBC Capital Markets maintained Becton, Dickinson and Company (NYSE:BDX) with “Hold” rating. On Tuesday, April 10 the firm earned “Buy” rating by Citigroup. On Tuesday, February 6 Jefferies maintained the shares of BDX in report with “Buy” rating. In Thursday, June 21 report J.P. Morgan upgraded the stock to “Buy” rating. On Tuesday, February 6 Piper Jaffray maintained Becton, Dickinson and Company (NYSE:BDX) rating. Piper Jaffray has “Buy” rating and $260.0 target.

For more Becton, Dickinson and Company (NYSE:BDX) news announced briefly go to: Globenewswire.com, 247Wallst.com, Schaeffersresearch.com, Streetinsider.com or Benzinga.com. The titles are as follows: “BD, Heart to Heart International and the NAFC Announce 2018 Grantees for a Multi-Year Point of Care Testing Initiative …” announced on June 27, 2018, “Top Analyst Upgrades and Downgrades: Charter Communications, Corning, Kohl’s, Lululemon, Nike, Verizon and More” on June 21, 2018, “2 Medical Technology Stocks Named Top Picks by JP Morgan Analyst” with a publish date: June 21, 2018, “Becton Dickinson (BDX) Names John DeFord as CTO” and the last “Becton Dickinson Positioned For Top-, Bottom-Line Outperformance, JPMorgan Says In Upgrade” with publication date: June 21, 2018.

Becton, Dickinson and Company (NYSE:BDX) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.